跳至主要内容
临床试验/CTRI/2024/08/071960
CTRI/2024/08/071960尚未招募2 期

Efficacy of Metformin in preventing Platinum and/or Taxane induced Peripheral Neuropathy :Double blind, Placebo , Randomized controlled trial - EMPPN trial

Jawaharlal Institute of Postgraduate Medical Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients planned for receiving Platinum or Taxane based chemotherapy regimens
  • 2.Planned for a minimum of 18 weeks of chemotherapy
  • 3.Curative or Palliative intent

排除标准

  • 1.Patients who have already received Chemotherapy
  • 2.Patients who have previously received neurotoxic or neurmodulating medications ( Gabapentin,Amitrypillie,Pregabalin, etc)
  • 3.Patients already on metformin
  • 4.Patients with pre existing neuropathic conditions
  • 5. Renal Impairment( eGFR less than 60ml/min) Cardiac Failure, Liver Failure
  • 6.Body mass Index less than 18

研究者

相似试验